R. Pratap et S. Shousha, BREAST-CARCINOMA IN WOMEN UNDER THE AGE OF 50 - RELATIONSHIP BETWEEN P53 IMMUNOSTAINING, TUMOR GRADE, AND AXILLARY LYMPH-NODE STATUS, Breast cancer research and treatment, 49(1), 1998, pp. 35-39
There is evidence to suggest that breast carcinoma in young women beha
ves in a more aggressive manner than in older women. As positive immun
ostaining for p53 has also been associated with increased tumour aggre
ssiveness, this study was aimed at finding out whether patients under
the age of 50 years have a higher prevalence of p53 positivity in thei
r tumours. The inter-relationships between age, p53, tumour grade, and
axillary lymph node status were also investigated. Two hundred and tw
enty nine invasive carcinomas were studied. One hundred and eight pati
ents were under the age of 50, and 121 were at or above that age. The
specific p53 monoclonal antibody DO7 and the avidin-biotin complex imm
unoperoxidase technique were used. Fifty seven tumours (25%) showed va
riable degrees of p53 positivity. The incidence of positivity was slig
htly higher in women under the age of 50 as compared with those at or
above that age (29% (31/108) vs. 21% (26/121), respectively), but the
difference was not statistically significant (p < 0.05). On the other
hand, in invasive ductal carcinoma (191 cases), p53 positivity was sig
nificantly related to high tumour grade (7% in grade I [1/14], 19% in
grade II [20/105], and 43% in grade III [31/72]; p < 0.0001 [I-II vs I
II]), p53 positivity was also significantly related to the presence of
extensive (more than three) axillary lymph node metastases (p53 posit
ivity being 22% in node negative tumours [40/178], 18% in tumours with
three or less positive nodes [6/33], and 61% in tumours with more tha
n 3 positive nodes [11/18]; p = 0.0033 [second vs third group]). Both
features were also significantly more common in the younger age group.
The results suggest that the slightly higher incidence of p53 positiv
ity seen in tumours from younger patients, is probably related to the
significantly higher incidence of grade III tumours in these patients.